Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marker feedback and adherence to monthly Bonviva in postmenopausal osteoporosis
2005-005529-74Phase 4Completed
- Sponsor
- Roche
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ibandronic acid in postmenopausal osteoporosis and osteoporosis (2 arms), sponsored by Roche. Primary endpoints: Adherence and Impact of serum CTX feedback on adherence. Started Feb 2006; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosisosteoporosis
Beyond the preview
Go deeper on 2005-005529-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005529-74.